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2012Objective: The study objective was to investigate whether, in patients undergoing surgery for degenerative
mitral valve disease, associated right ventricular remodeling and dysfunction are stronger determinants of
preoperative organ dysfunction and prognosis than functional tricuspid regurgitation.
Methods: From January 2001 to January 2011, 4197 patients underwent primary mitral valve surgery for
degenerative valve disease at Cleveland Clinic. Using a quasi-experimental enriched study design, 781 patients
were randomly selected within each grade of functional tricuspid regurgitation. Renal function was assessed by
glomerular filtration rate and blood urea nitrogen, and hepatic function was assessed by Model for End-stage
Liver Disease (MELD) score. Preoperative and postoperative right ventricular morphology and function were
measured de novo on stored echocardiographic images. To assess survival, 3471 patient-years of follow-up
data were available for analysis.
Results: Several preoperative right ventricular variables, but not functional tricuspid regurgitation grade
(P>.05), were associated with preoperative renal and hepatic dysfunction, but neither was associated with early
mortality (<6 months after surgery). However, worse preoperative right ventricular myocardial performance
index (P ¼ .001), but not functional tricuspid regurgitation grade (P>.2), was among the risk factors for later
mortality. Postoperative unadjusted right ventricular function, but not functional tricuspid regurgitation grade
(P  .2), was associated with both early (P ¼ .04) and later (P ¼ .01) mortality, but in multivariable analysis
appeared to be a surrogate for worse preoperative condition.
Conclusions: Together with patient comorbidities and operative factors, right ventricular morphology and
function are associated more strongly with preoperative organ dysfunction and prognosis than is functional
tricuspid regurgitation severity in patients undergoing surgery for degenerative mitral valve disease. Our
previous study showed that tricuspid valve repair remains the most effective treatment to improve right
ventricular function. (J Thorac Cardiovasc Surg 2014;148:2012-20)Supplemental material is available online.he Cleveland Clinic Lerner College of Medicine,a Cleveland, Ohio;
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The Journal of Thoracic and Cardiovascular SurThis is the last of a 3-part series examining the hypothesis
that left-sided events resulting in functional tricuspid
regurgitation (TR) also lead to right ventricular (RV)
dysfunction. If true, this has important implications for
preoperative surveillance of patients with left-sided valve
disease, timing of surgery, choice of procedure (more
particularly, of whether or not to perform concomitant
tricuspid valve [TV] repair), postoperative management,
and surgical outcomes. All 3 studies are based on an
enriched quasi-experimental study design.
Part 1 focused on understanding the importance of preop-
erative RV dysfunction and functional TR accompanying
mitral valve disease.1 We found that increasing TR grade
was associated with higher RV pressure, increased tethering
distance, larger right atrial size, and worsening RV function
measured by both tricuspid annular plane systolic excursion
(TAPSE) and myocardial performance index (MPI),
particularly in 3þ/4þ TR. We concluded that RV dysfunc-
tion is likely as important as TR because it offers an
explanation for the negative prognostic importance of TR.2
Part 2 focused on follow-up measurements of RV
function and TR after mitral valve surgery.3 We foundgery c November 2014
Abbreviations and Acronyms
BUN ¼ blood urea nitrogen
MPI ¼ myocardial performance index
MR ¼ mitral regurgitation
RV ¼ right ventricular
TAPSE ¼ tricuspid annular plane systolic excursion
TR ¼ tricuspid regurgitation
TTE ¼ transthoracic echocardiography
TV ¼ tricuspid valve
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erative TR over the ensuing 3 years, but mild worsening of
RV function. In patients with 3þ/4þ preoperative TR,
mitral repair alone reduced postoperative TR and improved
RV function; however, TR of 2þ or greater returned
postoperatively, and RV function worsened within 3 years,
unlike in patients who had concomitant TV repair. We
concluded that concomitant TV repair in patients with
3þ/4þ TR effectively and durably eliminated severe TR
and was associated with an improvement of RV function
toward normal, supporting an aggressive approach to
important functional TR.
Part 3 focuses on clinical outcomes. We hypothesize that
RV function and morphology may be more important
prognostic markers than severity of TR for patients with
functional TR undergoing mitral valve surgery. To test
this hypothesis and understand the implications of RV
function and morphology and TR for patient care
and management, we investigated the association of
preoperative RV morphology and dysfunction with organ
dysfunction (renal and hepatic) and short- and long-term
prognoses, and the effect of postoperative evolution of RV
remodeling and TR on survival.METHODS
From January 2001 to January 2011, 4197 patients underwent
primary mitral valve repair or replacement, with or without TV repair,
for degenerative valve disease at Cleveland Clinic. From the 3163
patients who met our inclusion and exclusion criteria of no structural
TV disease, no intrinsic RV disease, and no evidence of coronary artery
disease,1 200 were randomly selected from each preoperative TR grade
0þ, 1þ, and 2þ on transthoracic echocardiography (TTE); all 181
patients with grade 3þ or 4þ TR were included, totaling 781 patients
(a quasi-experimental study design). Clinical grading of TR included
evaluation of color TR jet area/right atrial area, vena contracta, proximal
isovelocity surface area, and hepatic vein flow reversal.4-7 The study
incorporated all patients in the 2 previous parts of this study, but
doubled the study size to include more recent cases, thus increasing
statistical power to detect associations with clinical outcomes. An
important aspect of the study strategy was to include a full spectrum
of TR grades, from no TR to severe.
This quasi-experimental study design accomplishes at least the
following important things. First, it enriches the study with patients
who potentially have RV dysfunction who may otherwise be lost in the
overwhelming majority of patients with no TR and no RV dysfunction.The Journal of Thoracic and CarSecond, it reduces by a factor of 5 the number of echocardiographic images
that must be quantitatively assessed, permitting us to concentrate on the
most important images. Third, it obviates any bias that may result from
TR misclassification on clinical TTEs because of measurement error,
intrinsic variability of functional TR, or interobserver variability. Finally,
it neutralizes any effect of referral pattern. At increasingly higher grades
of TR, average characteristics of patients—demographics, symptom-
atology, and renal and hepatic function—were progressively less favorable
(Tables 1 and 2).
Data Sources
Organ dysfunction. Clinical data were extracted from the
Cardiovascular Information Registry, a prospectively maintained registry,
the clinical laboratory database, and the echocardiographic database. These
and all other data used in this study were approved for use in research by the
institutional review board, with patient consent waived.
Right heart morphology and function. De novo measure-
ments were made offline from recorded echocardiograms for various right
heart morphology and function variables before and after surgery, strictly
following joint guidelines of the American Society of Echocardiography
and European Association of Echocardiography.4 These included 4 mea-
surements of right atrial morphology, 9 measurements of RV morphology,
8 measurements of RV function, and 3 measurements of valve dysfunction
(Appendix E1). We used ProSolv Cardiovascular Analyzer 3.5 (ProSolv
Cardiovascular, Indianapolis, Ind) and Syngo Dynamics 9.5 (Siemens
Medical Solutions, Inc, Ann Arbor, Mich). Measurements were averaged
over 3 cardiac cycles. It was possible to do this accurately in 137 of 139
patients in atrial fibrillation with no more variability than measurements
from patients in sinus rhythm. All 781 patients had early postoperative
TTEs. For patients followed at Cleveland Clinic, TTEs were obtained at
approximately yearly intervals (Figure E1). Three observers (Y.Y., R.D.,
L.M.V.A.) collected echocardiographic data; interobserver and
intraobserver variability for key variables are described in Appendix E1.
Survival. Survival data were obtained primarily by active follow-up at
2 and 5 years after surgery. These data were supplemented by interrogation
of the Social Security Administration Death Master File for vital status,
with a closing date of January 23, 2011.8,9 Median follow-up was 4.0 years
(mean, 4.4  3.0 years). Among surviving patients, 25% were followed
more than 7 years and 10% were followed more than 9 years. A total of
3471 patient-years of data were available for analysis.
Data Analysis
Risk factors for preoperative organ dysfunction. Multi-
variable linear regression was used to identify preoperative factors (in
particular measures of RV function, right heart morphology, and TR)
associated with preoperative renal dysfunction, indicated by estimated
glomerular filtration rate and blood urea nitrogen (BUN), and with
preoperative liver dysfunction, indicated by the Model for End-stage Liver
Disease (MELD) score.10 Variables considered in this analysis are listed in
Appendix E2, and bagging was used for variable selection.11,12 This
process involved random resampling and automated stepwise selection
using variables listed in Appendix E2 (entry criterion P< .10, retention
criterion P<.05). All variables with bootstrap reliability of 50% or greater
were retained in the final model.
Postoperative evolution of right ventricular function,
right heart morphology, and tricuspid regurgitation. RV
function, right heart morphology, and TR grade were analyzed longitudi-
nally after surgery for pattern of change across time. Nonlinear mixed-
model analysis was used to resolve the number of time phases to form a
temporal decomposition model and to estimate shaping parameters of
each phase.12-14 Implementation of the temporal decomposition model
was by a nonlinear mixed-effects regression model14 for continuous
repeated measurements and a nonlinear mixed-effects ordinal logisticdiovascular Surgery c Volume 148, Number 5 2013
TABLE 1. Preoperative patient characteristics and surgical management according to tricuspid valve regurgitation grade
Variable
Tricuspid valve regurgitation grade
Py
0 (n ¼ 200) 1þ (n ¼ 200) 2þ (n ¼ 200) 3þ/4þ (n ¼ 181)
n*
No. (%) or
Mean ± SD n*
No. (%) or
Mean ± SD n*
No. (%) or
Mean ± SD n*
No. (%) or
Mean ± SD
Demographics
Age (y) 200 54  11 200 59  11 200 64  12 181 70  11 <.0001
Female 200 56 (28) 200 77 (39) 200 82 (41) 181 103 (57) <.0001
Body surface area (m2) 200 2.0  0.24 200 2.0  0.25 200 1.9  0.25 181 1.9  0.26 <.0001
Cardiac morbidity
NYHA functional class 194 191 189 171 <.0001
I 87 (45) 67 (35) 71 (38) 35 (20)
II 86 (44) 104 (54) 86 (46) 86 (50)
III 21 (11) 19 (9.9) 29 (15) 49 (29)
IV 0 (0) 1 (0.52) 3 (1.6) 1 (0.58)
Noncardiac comorbidity
Bilirubin (mg$dL1) 200 0.70  0.46 197 0.75  0.48 199 0.82  0.43 177 0.86  0.47 <.0001
BUN (mg$dL1) 199 17  4.6 200 18  5.2 200 19  6.0 181 23  11 <.0001
Creatinine (mg$dL1) 200 0.94  0.18 199 0.95  0.22 199 0.98  0.23 180 1.1  0.57 .2
Hematocrit (%) 198 42  4.0 199 41  5.1 199 40  4.3 178 39  5.0 <.0001
MELD score 200 7.2  1.2 200 7.5  1.7 200 8.0  2.2 181 8.8  2.6 <.0001
Surgery
Mitral valve surgery 200 200 200 181 <.0001
Repair 192 (96) 189 (94) 181 (92) 146 (81)
Replacement 8 (4.6) 11 (5.5) 19 (9.5) 35 (19)
TV repairz 200 0 (0) 200 3 (1.5) 200 23 (12) 181 126 (70) <.0001
BUN, Blood urea nitrogen; MELD, Model for End-stage Liver Disease; NYHA, New York Heart Association; SD, standard deviation; TV, tricuspid valve. *Patients with data
available. yFor categoric variables, Mantel–Haenszel test of linear trend with increasing TV regurgitation grade; for continuous variables, equivalent test of Pearson correlation
coefficient. zOne patient had TV replacement.
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Dregression model for ordinal repeated measurements (SAS PROC
NLMIXED; SAS Institute Inc, Cary, NC).
Preoperative risk factors for death. Survival was assessed
nonparametrically by the Kaplan–Meier method and parametrically
by a multiphase hazard model.12 Reliable risk factors were identified
by bagging using variables listed in Appendix E2, as described
previously.11,12
Postoperative risk factors for death. The association of the
longitudinal patterns of postoperative TAPSE and TR with mortality was
assessed by treating TAPSE and TR as time-varying covariables, with
preoperative measurements as baseline measurements.14
Missing data. Sporadic missing values (Figure E2), under the
assumption of being missing at random, were imputed through 5-fold
multiple imputation15 using the Markov Chain Monte Carlo technique
with PROC MI (version 9.1, SAS Institute Inc). Regression coefficients
and their variance–covariance matrix were estimated by combining results
from the 5 models using PROC MIANALYZE (SAS Institute Inc).
Presentation
Continuous variables are summarized by mean  standard deviation or
by median, 15th, and 85th percentiles, consistent with 1 standard
deviation. Categoric data are summarized by frequencies and percentages.
Uncertainty is expressed by 68% confidence limits equivalent to 1
standard error. All analyses were performed using SAS statistical software
(version 9.1; SAS Institute Inc).RESULTS
Risk Factors for Preoperative Organ Dysfunction
Renal dysfunction, manifested by lower preoperative
estimated glomerular filtration rate, was associated with2014 The Journal of Thoracic and Cardiovascular Surlonger TV tethering distance, smaller TV fractional
shortening, lower TAPSE, and larger left atrial volume, as
well as older age, insulin-treated diabetes, and heart failure
(Table 3). Renal dysfunction, manifested by higher
preoperative BUN, was associated with higher RV systolic
pressure, longer TV tethering distance, lower left ventricu-
lar ejection fraction, and larger end-diastolic right atrial
area, as well as older age and other comorbidities (Table 3).
Liver dysfunction, manifested by higher MELD score,
was associated with larger end-systolic right atrial area,
smaller RV basal diameter, higher RV systolic pressure,
larger end-systolic TV diameter, longer TV tethering dis-
tance, lower left ventricular ejection fraction, and larger
end-systolic left atrial area, as well as heart failure (Table 3).
Neither renal nor liver dysfunction was associated with
increasing degree of TR or quantitative measurements of
TR, including vena contracta and TR jet area (P>.05).
Postoperative Evolution of Right Ventricular
Function and Tricuspid Regurgitation
An in-depth analysis of the effect of mitral valve repair
(with or without TV repair) on postoperative RV function
has been published in Part 2 of this series,3 and the findings
were the same in our expanded patient cohort. To summa-
rize, after surgery, TAPSE initially declined but then rapidly
improved over the next 6 months (Figure E3). MPI similarly
worsened immediately after surgery and then improvedgery c November 2014
TABLE 2. Left and right heart echocardiographic findings according to tricuspid valve regurgitation grade
Variable
Tricuspid valve regurgitation grade
Py
0 (n ¼ 200) 1þ (n ¼ 200) 2þ (n ¼ 200) 3þ/4þ (n ¼ 181)
n*
No. (%) or
Mean ± SD n*
No. (%) or
Mean ± SD n*
No. (%) or
Mean ± SD n*
No. (%) or
Mean ± SD
Mitral valve regurgitation grade 200 200 200 181 .2
1þ 1 (0.5) 0 (0) 0 (0) 0 (0)
2þ 0 (0) 2 (1) 2 (1) 3 (1.7)
3þ 23 (12) 36 (18) 21 (11) 25 (14)
4þ 176 (88) 162 (81) 177 (89) 153 (85)
LV mass index (g$m2) 194 130  81 195 130  31 195 130  34 172 130  88 .3
Left atrial diameter (cm) 187 4.6  0.69 189 4.7  0.87 192 4.9  0.84 166 5.0  0.90 <.0001
LV end-diastolic volume (mL) 195 150  45 197 150  45 195 150  45 172 140  42 .0005
LV end-systolic volume (mL) 195 49  24 197 51  24 194 47  24 172 49  26 .4
LV ejection fraction (%) 200 59  5.8 199 59  6.9 200 58  6.3 180 57  8.4 .02
RV systolic pressure (mm Hg) 200 23  12 200 33  15 200 44  19 181 50  22 <.0001
Pulmonary valve regurgitation grade 199 198 197 179 <.0001
0 192 (96) 107 (54) 83 (42) 67 (37)
1þ 7 (3.5) 86 (43) 20 (10) 19 (11)
2þ 0 (0) 5 (2.5) 94 (48) 13 (7.3)
3þ 0 (0) 0 (0) 0 (0) 65 (36)
4þ 0 (0) 0 (0) 0 (0) 15 (8.4)
LV, Left ventricular; RV, right ventricular; SD, standard deviation. *Patients with data available. yFor categoric variables, Mantel–Haenszel test of linear trend with increasing TV
regurgitation grade; for continuous variables, equivalent test of Pearson correlation coefficient.
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TR was 0 or 1þ in the majority of patients (Figure E5).Preoperative Risk Factors for Death
Instantaneous risk of death varied across time and was
decomposed into 2 components (Figure E6): an early
peaking phase of risk occurring within 6 months of surgery
and an accelerating phase of risk. Risk factors associated
with deaths occurring in the early peaking phase included
complete heart block or use of a pacer, mitral valve
replacement instead of repair, and larger preoperative left
ventricular end-systolic volume index (Table 4). Neither
preoperative degree of TR measured qualitatively (P>.2)
or quantitatively nor RV remodeling or dysfunction
(P> .05) was associated with these early deaths. Death
occurring 6 months or more after surgery was associated
with higher preoperative MPI (Figure 1, A), and smaller
left atrial diameter, as well as older age, smoking history,
longer aortic clamp time, mitral valve replacement instead
of repair, and higher preoperative BUN. Although
preoperative renal dysfunction was associated with risk of
later death (Figure 1, B), preoperative liver dysfunction
was not (P>.05).Postoperative Right Ventricular Function, Tricuspid
Regurgitation, and Mortality
The initial decline in RV function after mitral valve
surgery as shown for TAPSE (Figure 2) coincided with
the high early hazard phase of death. The subsequent rapidThe Journal of Thoracic and Carimprovement in RV function coincided with the rapid
decrease of hazard. Thus, there was an apparent parallel
relation of the longitudinal pattern of postoperative RV
function and early (P¼ .04) and late (P¼ .01) risk of death.
However, after accounting for preoperative risk factors for
mortality by multivariable analysis, this relationship was
more likely to be a surrogate for these other preoperative
factors (early hazard phase risk-adjusted P¼ .2; late hazard
phase risk-adjusted P ¼ .08). We found no relationship,
either unadjusted (P > .2) or after accounting for
preoperative risk factors (P> .4), between the temporal
pattern of postoperative TR and mortality. The majority of
patients with severe TR (70%) underwent concomitant
TV repair (Table 2).DISCUSSION
Study Design
Attempts to understand how long-term prognosis is
affected by functional TR have focused on patients already
exhibiting RV failure16 or important TR,17 but we have
found no study investigating how the evolution of RV
morphology and function and TR affects survival. Our
intention in Part 3 of our study was to fill this gap and
determine the relationships between TR, right heart
morphology, and RV function and outcomes. We used the
same quasi-experimental approach as in Parts 1 and 2
of our study,1,3 expanding the population to increase
statistical power, but still examining a pure population of
patients with degenerative mitral valve disease and no,diovascular Surgery c Volume 148, Number 5 2015
TABLE 3. Risk factors for preoperative organ dysfunction
Risk factor Coefficient ± SE P
Reliability
(%)*
Renal dysfunction
Lower eGFR
Longer TV tethering distancey 1.3  0.63 .04 78
Smaller TV fractional
shorteningz
31  14 .03 61
Lower TAPSEx 0.26  0.104 .01 67
Larger LA volumek 2.1  0.82 .01 81
Older age 0.47  0.051 <.0001 100
Insulin-treated diabetes 23  7.5 .002 91
Heart failure 6.6  1.6 <.0001 94
Higher BUN
Higher RV systolic pressure 0.0302  0.012 .01 78
Longer TV tethering
distance{
1.4  0.50 .005 72
Lower LV ejection fraction# 5.7  1.4 <.0001 79
Larger end-diastolic
RA area**
0.40  0.10 <.0001 81
Older ageyy 1.8  0.303 <.0001 99
Chronic obstructive
pulmonary disease
3.5  0.82 <.0001 87
Heart failure 2.8  0.62 <.0001 99
Carotid disease 3.3  1.2 .005 57
No peripheral arterial
disease
3.1  1.4 .02 41
Liver dysfunction
Higher MELD score
Larger end-systolic RA area 0.012  0.0013 <.0001 64
Smaller RV basal diameter 0.043  0.012 .004 58
Higher RV systolic pressurezz 0.017  0.00604 .004 88
Larger end-systolic TV
diameterxx
0.061  0.031 .05 75
Longer TV tethering
distance{
0.028  0.015 .05 68
Lower LV ejection fraction 0.13  0.039 .0008 82
Larger end-systolic LA areakk 0.027  0.0091 .004 89
Male 0.089  0.014 <.0001 95
Never smoked 0.031  0.014 .02 60
Heart failure 0.094  0.018 <.0001 99
Insulin-treated diabetes 0.22  0.086 .01 62
eGFR, Estimated glomerular filtration rate; LA, left atrial; LV, left ventricular;
MELD, Model for End-stage Liver Disease; RA, right atrial; RV, right ventricular;
SE, standard error; TAPSE, tricuspid annular plane systolic excursion; TV, tricuspid
valve; BUN, blood urea nitrogen. *Number of times factor appeared in 500 bootstrap
models. y(1/TV tethering distance), inverse transformation. z(TV fractional
shortening)2, squared transformation. xExp(TAPSE), exponential transformation.
k(60/LA volume), inverse transformation. {(TV tethering distance)2, squared
transformation. #(50/LV ejection fraction), inverse transformation. **(RA area in
diastole/20)2, squared transformation. yyExp(age/50), exponential transformation.
zz(RV systolic pressure/40)2, squared transformation. xxLog(end-systolic TV
diameter), logarithmic transformation. kk(End-systolic LA area/30)2, squared
transformation.
TABLE 4. Incremental risk factors for death
Risk factor Coefficient ± SE P
Reliability
(%)*
Early
Complete heart block/pacer 2.0  0.65 .002 46
Mitral valve replacement 2.8  0.73 .0001 43
Larger LV end-systolic
volume indexy
0.32  0.12 .008 51
Late
Higher preoperative MPIz 1.2  0.37 .001 55
Smaller left atrial diameter 55
4.2-<4.7 cm vs<4.2 cm 1.2  0.57 .04
4.7-<5.2 cm vs<4.2 cm 1.1  0.47 .02
5.2 vs<4.2 cm 1.5  0.502 .0003
Older agex 1.02  0.26 .0001 86
History of smoking 1.1  0.36 .002 75
Longer aortic clamp timek 0.77  0.28 .008 46
Mitral valve replacement 0.83  0.38 .03 67
Higher preoperative BUN{ 0.38  0.72 <.0001 88
BUN, Blood urea nitrogen; LV, left ventricular;MPI, myocardial performance index;
SE, standard error. *Number of times factor appeared in 500 bootstrap models.
y(LV end-systolic volume index/25)2, squared transformation. zLog(MPI), logarith-
mic transformation. xExp(age/50), exponential transformation. k(Aortic clamp
time/75)2, squared transformation. {(BUN/20)2, squared transformation.
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disease, intrinsic RV disease, or evidence of coronary
artery disease. With this study design, exact TR grade is
less important than obtaining a representative spectrum of
RV function.2016 The Journal of Thoracic and Cardiovascular SurRisk Factors for Preoperative Organ Dysfunction
In accordance with previous studies, preoperative organ
dysfunction correlated with patient characteristics and
morphology and function of the left side of the heart.18,19
In addition, preoperative renal and liver dysfunction were
associated with dilatation of the right heart and worse RV
function, but not with TR. If one believes that functional
TR is caused by pulmonary congestion, elevated
pulmonary artery pressure, and RV dilatation and
dysfunction, it makes sense that right heart morphology
and function may be of more prognostic importance than
TR and suggests that we pay more attention to right heart
morphology and RV function when evaluating patients
with degenerative mitral valve disease who have impaired
kidney and liver function. The association of right heart
remodeling and dysfunction with preoperative organ
failure provides more insight into why patients with right
heart failure caused by mitral regurgitation (MR)
experience renal and hepatic dysfunction.20,21
Preoperative Risk Factors for Death
Overall survival after surgery was excellent, with early
elevated hazard of death giving way to a later lower, but
steadily increasing, hazard phase. This biphasic pattern
also was seen in an earlier study of mitral valve repair for
degenerative valve disease.22 In the previous study, the
hazard for reoperation showed the same pattern, suggesting
a possible connection between repair failure and survival,
an association we did not examine in this study.
Risk factors for early death all point to known factors
associated with disease severity.23-26 The fact that returngery c November 2014
FIGURE 1. Relationship of preoperative risk factors to 5-year survival after mitral valve surgery with or without concomitant TV repair. A, Preoperative
RVMPI. Solid line represents point estimates enclosed within a 68% confidence band for an individual with left ventricular end-systolic volume index¼ 25
mL$m2, no complete heart block/pacer, left atrial diameter ¼ 4.2 to 4.7 cm, mitral valve repair, no history of smoking, BUN ¼ 20 mg$dL1, and aortic
clamp time ¼ 72 minutes. B, Preoperative BUN. Depiction is as in (A) except that MPI has been set at 0.42. BUN, Blood urea nitrogen; MPI, myocardial
performance index.
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later after mitral valve surgery explains why neither TR
nor right heart morphology and function were risk factors
for early death.
Risk of later death was associated with expected
factors related to patient characteristics, including renal
dysfunction, mitral valve replacement rather than repair,
and the complexity of surgery as measured by aortic clamp
time.18,26 Smaller left atrial diameter is unlikely to be a riskThe Journal of Thoracic and Carfactor for later death, because other studies have more often
linked left atrial dilatation to increased risk of
cardiovascular events and death.29-31
Preoperative TR was not associated with increased
mortality, neither early nor late. This is contrary to other
studies that have demonstrated a relationship between
residual and worsening TR and decreased survival.32
Severe preoperative functional TR has been associated
with recurrent or residual TR after correction of the mitraldiovascular Surgery c Volume 148, Number 5 2017
FIGURE 2. Instantaneous risk of death and postoperative TAPSE.Orange dashed line depicts the temporal trend of postoperative TAPSE.Blue solid line rep-
resents parametric estimate of risk of death. (Note expansion of early deaths compared with Figure E3, A.) TAPSE, Tricuspid annular plane systolic excursion.
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mixed patient population in whom mitral pathologies
other than degenerative disease were present, whereas we
focused purely on degenerative disease with severe MR
being the indication for surgery and with each grade of
functional TR represented in equal proportions.
In support of our hypothesis that RV dysfunction might
be more important than TR, we found that worse
preoperative RV function, specifically higher MPI, was
associated with later death; however, this effect was small.
Gallego-Delgado and colleagues35 also found preoperative
TAPSE to be associated with worse prognosis in patients
undergoing mitral valve surgery.
Postoperative Right Ventricular Function, Tricuspid
Regurgitation, and Mortality
The postoperative longitudinal pattern of TR was not
associated with survival, but the postoperative pattern of
RV dysfunction was, before we adjusted for preoperative
risk factors. In this and our previous study, we observed a
decrease in TAPSE in the immediate postoperative period,
followed by recovery toward normal within a few months.3
The effect does not last, but within 1 year after surgery,
TAPSE slowly declines as hazard of death slowly increases.
However, multivariable analysis revealed that postoperative
changes in RV function and the risk of death appeared to be
generally independent phenomena.
In contrast to the parallel, albeit largely independent,
change in RV function with risk of death, we did not find
even a univariable association between postoperative
changes in TR and risk of death. We speculate that, driven
by mitral valve disease, RV dysfunction and TR are both
markers of advanced disease, and at the same time are2018 The Journal of Thoracic and Cardiovascular Surboth part of a self-perpetuating vicious cycle. Irrespective
of causality, treating TR remains the best option to break
the cycle, as demonstrated in Part 2 of this series.3 The
majority of patients with severe TR underwent concomitant
TV repair in our expanded cohort as well.
In patients with degenerative mitral valve disease
and severe functional TR, concomitant TV repair
effectively eliminated TR and was associated with
improved RV function, in most cases nearing normal, and
the effect was durable. After mitral valve repair alone, RV
dysfunction and TR initially improved, but returned to
preoperative levels within 3 years. A slow return of RV
dysfunction also was seen in our expanded cohort. An
aggressive and more liberal approach to TV repair in these
patients is more likely to secure better long-term RV
function.
Study Strengths and Limitations
Because this is a retrospective, albeit quasi-experimentally
designed study, values for some preoperative and
postoperative variables are incomplete. All patients
underwent preoperative and immediate postoperative
echocardiography. Over time, however, the number of
patients returning for routine follow-up echocardiograms
decreased. Most of the right heart variables were available
from preoperative echocardiograms because of our standard
protocol of evaluating patients before surgery. Postoperative
echocardiograms had more missing data for right heart
variables because a full echocardiogram is not routinely
ordered. More follow-up echocardiograms were available
for local patients.
Severity of TR used for selecting and categorizing
patients was based on routine qualitative measurementsgery c November 2014
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phy echocardiographic grading criteria.4 We accepted the
TR interpretations used for clinical decision-making;
however, interobserver and intraobserver variability among
clinical sonographers were not assessed, and we recognize
that there is also intrinsic variability of functional TR.
Our quasi-experimental study design makes it robust
against TR misclassification as long as there is a positive
correlation between TR and RV dysfunction, as
demonstrated in Part 1 of this series.1 It is also robust
against referral bias.
Only clinical, not research-quality, echocardiograms
were available for measuring RV morphology and function,
and differences in echocardiographic quality and viewing
modalities could have affected the data. Further,
several readers participated in obtaining de novo right
heart echocardiographic measures. Interobserver and
intraobserver variability were assessed for these variables,
and the variations should have introduced little bias into
our study (Appendix E1, including associated Appendix
Figures E1-E4 and Appendix Tables E1 and E2).
It is also possible that our measurements may have been
affected by the load dependence of TAPSE and MPI.36,37
Particularly in patients with severe TR, these
echocardiographic measures may not solely reflect
intrinsic RV function. Further, in patients with atrial
fibrillation, these measurements are somewhat more
difficult to obtain, and more data are missing.
Because of the small number of deaths that occurred in
our patient population, the effects of TR, RV morphology
and function, and other factors may not have been detected.
For example, studying self-reported functional health status
or quality of life may have disclosed stronger relationships
with RV dysfunction and TR.35 Outcomes included the
effect of TV repair according to current policy.
CONCLUSIONS
RV remodeling and dysfunction, rather than degree of
TR, help explain preoperative organ dysfunction and
survival in patients undergoing surgery for degenerative
mitral valve disease. Longitudinal trend of postoperative
RV dysfunction more closely parallels risk of death than
does pattern of TR. Given that RVmorphology and function
are important to the prognosis of patients undergoing
surgery for degenerative mitral valve disease, clinicians
should pay more attention to the state of the RV when
determining management and prognosis. Part 2 of this
series showed that TV repair remains the most effective
treatment to improve and secure better RV function.
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APPENDIX E1. INTEROBSERVER AND
INTRAOBSERVER VARIABILITY
Interobserver variability for measurements of TAPSE and
MPI function was assessed by 5 observers using 17 randomly
selected echocardiograms from the overall collection of
echocardiograms used in this study. Observers were blinded
to results from other observers. Intraobserver variability on
all right heartmorphology and functionvariableswas assessed
by 1 observer (Y.Y.) using 20 randomly selected echocardio-
grams from the overall collection of echocardiograms used
in this study. Measurements were conducted 1 month apart.
Pearson correlation was used to quantify the variability
between different observers for TAPSE and MPI, and
reproducibility by the same observer for all RVmorphology
and function variables.
The least amount of variability existed between observers 1
and 5 (TAPSE, r ¼ 0.93; MPI, r ¼ 0.80; Appendix E1, Table
E1, and Figures E1 and E2); the relationship of TAPSE and
MPI measurements by observers 1 and 5 is plotted. More
variability existed between observers 1 and 2; both
contributed to measurement of RV morphology and function
in this study.
Intraobserver variability for all RV morphology and
function variables was analyzed for observer 1 (Appendix
E1, Table E2, and Figures E3 and E4). Pearson
correlations were greater than 0.9 for most variables,
indicating good reproducibility of the obtained
measurements. The most variability was in measuring
tethering area (r ¼ 0.64).
APPENDIX FIGURE E1. Interobserver correlation for TAPSE.
A, Scatter plot. Black line represents linear trend of correlation between
TAPSE measurements made by observers 1 and 5. B, Bland–Altman plot
for TAPSE measurements made by observers 1 and 5. TAPSE, Tricuspid
annular plane systolic excursion.
APPENDIX FIGURE E2. Interobserver correlation for MPI. A, Scatter
plot. Black line represents linear trend of correlation between MPI mea-
surements made by observers 1 and 5. B, Bland–Altman plot for MPI mea-
surements made by observers 1 and 5. MPI, Myocardial performance
index.
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APPENDIX FIGURE E3. Intraobserver correlation for TAPSE.
A, Scatter plot. Black line represents linear trend of correlation between
TAPSE measurements made by observer 1 on 2 different occasions. B,
Bland–Altman plot for TAPSE measurements made by observer 1 on 2
different occasions. TAPSE, Tricuspid annular plane systolic excursion.
APPENDIX FIGURE E4. Intraobserver correlation for MPI. A, Scatter
plot. Black line represents linear trend of correlation between MPI mea-
surements made by observer 1 on 2 different occasions. B, Bland–Altman
plot for MPI measurements made by observer 1 on 2 different occasions.
MPI, Myocardial performance index.
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APPENDIX TABLE E1. Interobserver variability: Pearson
correlation coefficients between observers
MPI TAPSE
Observer 1 vs observer 2 0.32 0.59
Observer 1 vs observer 3 0.40 0.76
Observer 1 vs observer 4 0.33 0.72
Observer 1 vs observer 5 0.80 0.93
Observer 2 vs observer 3 0.41 0.33
Observer 2 vs observer 4 0.59 0.36
Observer 2 vs observer 5 0.18 0.56
Observer 3 vs observer 4 0.32 0.86
Observer 3 vs observer 5 0.72 0.64
Observer 4 vs observer 5 0.15 0.68
MPI, Myocardial performance index; TAPSE, tricuspid annular plane systolic excur-
sion.
APPENDIX TABLE E2. Intraobserver variability: Pearson
correlation for observer 1
Pearson correlation
Right atrial end-diastolic area 0.98
Right atrial end-systolic area 0.97
Right atrial minor dimension 0.87
Right atrial major dimension 0.93
RV basal diameter 0.95
RV base-apex length 0.96
RV end-diastolic area 0.96
RV end-systolic area 0.94
RV subcostal wall thickness 0.92
RV distal diameter 0.99
RV proximal diameter 0.99
TV end-diastolic annulus diameter 0.96
TV end-systolic annulus diameter 0.94
Tethering area 0.64
Tethering distance 0.80
TR jet area 0.96
Tricuspid regurgitation vena contracta 0.94
TAPSE 0.73
TV closing/opening time 0.95
Ejection time 0.92
MPI 0.87
MPI, Myocardial performance index; RV, right ventricular; TAPSE, tricuspid annular
plane systolic excursion; TR, tricuspid regurgitation; TV, tricuspid valve.
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APPENDIX E2. Right heart, left heart, patient characteristics, and procedural variables used in multivariable analyses
Right heart
Atrium:
Remodeling: Right atrial area in systole (cm2), area in diastole (cm2), major dimension (cm), minor dimension (cm)
Ventricle:
Remodeling: RV base to apex length (cm), TV tethering distance (cm), TV tethering area (cm2), proximal diameter (cm), distal
diameter (cm), basal diameter (cm), end-diastolic area (cm), end-systolic area (cm), RV area fractional
shortening
Function: Systolic pressure (mm Hg), TAPSE (cm), MPI, TV diameter in systole (cm), TV diameter in diastole (cm), TV
diameter shortening (cm), TV fractional shortening, pulmonary valve resistance (dyne$cm/s2)
Valve dysfunction: Pulmonary regurgitation (grade 0-4þ), TR (grade 0-4þ), TR vena contracta
Patient
Demographic: Age (y), gender, weight (kg), height (cm), body surface area (m2), body mass index (kg$m2)
Symptoms: NYHA functional class (I-IV)
Valve dysfunction: Mitral valve regurgitation, aortic valve regurgitation
Coronary anatomy: Left main trunk disease (% stenosis), left anterior descending coronary artery system disease (maximum%
stenosis), right coronary artery system disease (maximum% stenosis), left circumflex coronary artery system
disease (maximum% stenosis)
Cardiac comorbidity: Atrial fibrillation, hypertension, history of cardiac disease, complete heart block/pacer, ventricular arrhythmia
Noncardiac comorbidity: Treated diabetes, insulin-treated diabetes, history of peripheral arterial disease, history of smoking, carotid
disease, popliteal disease, creatinine (mg$dL1), BUN (mg$dL1), bilirubin (mg$dL1), creatinine clearance,
hematocrit (%), glomerular filtration rate, history of renal disease, history of stroke, Model for End-stage Liver
Disease (MELD) score
Experience: Date of operation (years since January 1, 2001)
Left heart
Atrium: LA diameter (cm), volume (mL), volume index (mL$m2), systolic area (cm2)
Left ventricle:
Structure: Inner diameter in diastole (cm), inner diameter in systole (cm), diastolic volume (mL), systolic volume (mL),
diastolic volume index (mL$m2), systolic volume index (mL$m2)
Function: Fractional shortening, ejection fraction (%), relative wall thickness (wall stress)
Mass: Mass (g), mass index (g$m2), posterior wall thickness (cm), septal thickness (cm)
Support* Aortic clamp time (min)
Procedure* Mitral valve repair/replacement, TV repair/replacement
BUN, Blood urea nitrogen; LA, left atrial;MPI, myocardial performance index;NYHA, NewYork Heart Association; RV, right ventricular; TAPSE, tricuspid annular plane systolic
excursion; TR, tricuspid regurgitation; TV, tricuspid valve. *Not considered in the multivariable analyses of preoperative organ dysfunction.
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FIGURE E1. Number of patients with echocardiographic measurements available at and beyond various time points, and number of echocardiographic
measurements available for analysis.
FIGUREE2. Percentage of preoperative echocardiograms (781 total) with nonmissing values for indicated variables.MPI, Myocardial performance index;
RA, right atrial; RV, right ventricular; RVOT, right ventricular outflow tract; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation;
TV, tricuspid valve.
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FIGUREE3. Mean TAPSE over time. Solid line represents unadjusted estimates of temporal trend of the mean response of postoperative TAPSE. Symbols
represent data grouped (without regard to repeated measurements) within time frame to provide a crude verification of model fit. TAPSE, Tricuspid annular
plane systolic excursion.
FIGURE E4. Mean MPI over time. Solid line represents unadjusted estimates of temporal trend of the mean response of postoperative MPI. Symbols
represent data grouped (without regard to repeated measurements) within time frame to provide a crude verification of model fit. MPI, Myocardial
performance index.
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FIGURE E5. Prevalence of TR grades over time after mitral valve surgery with or without concomitant TV repair. Depiction is as in Figure E4. Solid line
represents unadjusted estimates of temporal trend of the prevalence of postoperative TR grades. Symbols represent data grouped (without regard to repeated
measurements) within time frame to provide a crude verification of model fit. TR, Tricuspid regurgitation.
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FIGURE E6. Death after mitral valve surgery. A, Instantaneous risk of death (hazard function) enclosed within a 68% confidence band equivalent to 1
standard error. B, Survival. Each circle represents a death, vertical bars represent 68% confidence limits equivalent to 1 standard error, and numbers in
parentheses represent number of patients traced beyond that point. Solid line enclosed within a dashed 68% confidence band represents parametric survival
estimates.
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